ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3166

HLA-B27 and Ankylosing Spondylitis Have Shared Effects on the Gut Microbiome

Mary-Ellen Costello1, Mark Asquith2, Kim-Anh Lê Cao3, Tammy Martin4, Sarah Diamond2, Michelle Beaumont5, Timothy D. Spector5, James T. Rosenbaum2 and Matthew A. Brown1, 1Translational Research Institute, Translational Genomics Group, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia, 2Oregon Health & Science University, Portland, OR, 3Translational Research Instiute, The University of Queensland Diamantina Institute, Brisbane, Australia, 4Ophthalmology, Oregon Health & Science Univ, Portland, OR, 5Dept of Twin Research and Genetic Epidemiology, King's College London, London, United Kingdom

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Ankylosing spondylitis (AS) and microbiome

  • Tweet
  • Email
  • Print
Session Information

Date: Wednesday, November 16, 2016

Title: Spondylarthropathies Psoriatic Arthritis – Pathogenesis, Etiology II

Session Type: ACR Concurrent Abstract Session

Session Time: 9:00AM-10:30AM

Background/Purpose: Evidence for a discrete intestinal microbiome signature in the terminal ileum (TI) of ankylosing spondylitis (AS) patients, compared to healthy controls, has recently been described. It has been hypothesised that HLA-B27 induces AS by effects on the intestinal microbiome, in turn driving spondyloarthritis by inducing immunological processes, particularly IL-23 production. Here we examine the effect of HLA-B27 on the composition of the intestinal microbiome in healthy individuals and twins, using culture independent 16S rRNA amplicon sequencing.

Methods: 135 samples from 6 intestinal sites were collected from otherwise healthy persons undergoing routine colorectal screening (age 40-75yrs). All patients were HLA-B typed and biopsies sequenced for the bacterial marker gene 16S rRNA and analysed. Further analysis was conducted using multivariate analysis package MixMC as implemented in R.The association between HLA-B27 status and intestinal microbiome was further examined in 1392 otherwise healthy twins with matched faecal 16S rRNA and genotype status from the TwinsUK registry. Linear mixed effects models were used to examine the association between the microbiome and genotype status. These models account for the correlation between twins within a family.

Results: Intestinal biopsy studies revealed that HLA-B27 genotype (n=10 B27+ and 85 B27- samples) influences overall microbial composition with increases in bacterial families Ruminococcaceae and Lachnospiraceae in the HLA-B27+ samples. Multivariate regression analysis of all samples demonstrated distinct clustering of HLA-B27+ from HLA-B27- samples (P=0.0063; PERMANOVA). The TI also showed clear and distinct clustering of HLA-B27+ from HLA-B27- samples driven by a decrease in Veillonellaceae (P<0.001) and the order Clostridiales (P<0.05), and increases in Bacteroidaceae (P<0.05) and Ruminococcaceae (P<0.05). The effect of genotype on the microbiome was further examined in the TwinsUK cohort (n=107 B27+ and 1285 B27- samples). HLA-B27 status was again associated with the bacterial families Ruminococcaceae, Lachnospiraceae and the order Clostridiales, in the same direction as seen in the intestinal biopsy data. This is consistent with the TI microbial signature previously described in AS cases and healthy HLA-B27+ patients.

Conclusion: This study shows that healthy HLA-B27+ individuals exhibit shared microbiota changes with AS, indicating an altered microbiota may be a primary event in AS pathogenesis rather than secondary to disease or its treatment. These findings support the hypothesis that HLA-B27 operates to cause AS through interaction with the intestinal microbiome, and suggests that therapies targeting the microbiome may be effective in AS prevention and/or treatment.


Disclosure: M. E. Costello, None; M. Asquith, None; K. A. Lê Cao, None; T. Martin, None; S. Diamond, None; M. Beaumont, None; T. D. Spector, None; J. T. Rosenbaum, Alcon Research Institute, 2,AbbVie, UCB, XOMA, Santen, Novartis, Medimmune, Cavtherx, Portage, Topivert, Regeneron, Allergan, Sanofi, Gilead and Mallinckrodt, 5; M. A. Brown, None.

To cite this abstract in AMA style:

Costello ME, Asquith M, Lê Cao KA, Martin T, Diamond S, Beaumont M, Spector TD, Rosenbaum JT, Brown MA. HLA-B27 and Ankylosing Spondylitis Have Shared Effects on the Gut Microbiome [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/hla-b27-and-ankylosing-spondylitis-have-shared-effects-on-the-gut-microbiome/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hla-b27-and-ankylosing-spondylitis-have-shared-effects-on-the-gut-microbiome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology